Patrick Wood
Stock Analyst at Morgan Stanley
(3.01)
# 1,281
Out of 4,829 analysts
87
Total ratings
40.62%
Success rate
2.28%
Average return
Main Sectors:
Stocks Rated by Patrick Wood
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GKOS Glaukos | Maintains: Underweight | $110 → $72 | $89.96 | -19.96% | 4 | May 6, 2025 | |
| GEHC GE HealthCare Technologies | Maintains: Equal-Weight | $86 → $78 | $69.87 | +11.64% | 6 | May 6, 2025 | |
| BDX Becton, Dickinson and Company | Maintains: Overweight | $280 → $196 | $167.22 | +17.21% | 4 | May 6, 2025 | |
| BLCO Bausch + Lomb | Maintains: Equal-Weight | $18 → $12 | $11.27 | +6.48% | 7 | May 6, 2025 | |
| TFX Teleflex | Maintains: Overweight | $191 → $173 | $125.11 | +38.28% | 5 | May 5, 2025 | |
| BAX Baxter International | Maintains: Underweight | $30 → $28 | $30.90 | -9.39% | 4 | May 5, 2025 | |
| SOLV Solventum | Maintains: Equal-Weight | $73 → $80 | $70.23 | +13.91% | 4 | Mar 5, 2025 | |
| TNDM Tandem Diabetes Care | Downgrades: Equal-Weight | $45 → $22 | $22.98 | -4.26% | 4 | Mar 5, 2025 | |
| PRCT PROCEPT BioRobotics | Maintains: Overweight | $105 → $95 | $53.11 | +78.87% | 2 | Feb 26, 2025 | |
| DXCM DexCom | Maintains: Equal-Weight | $75 → $82 | $84.67 | -3.15% | 7 | Feb 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $70 → $75 | $73.68 | +1.79% | 8 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $100 → $120 | $102.86 | +16.66% | 5 | Feb 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $104 → $102 | $82.26 | +24.00% | 5 | Dec 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $234 → $317 | $310.67 | +2.04% | 5 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $18 → $10 | $8.62 | +16.01% | 2 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $104 → $145 | $111.50 | +30.04% | 1 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $65 → $85 | $95.75 | -11.23% | 3 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $50 → $37 | $19.42 | +90.53% | 2 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $225 → $215 | $226.43 | -5.05% | 3 | Dec 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $36 | $13.06 | +175.65% | 1 | Dec 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $143.76 | - | 5 | Dec 11, 2017 |
Glaukos
May 6, 2025
Maintains: Underweight
Price Target: $110 → $72
Current: $89.96
Upside: -19.96%
GE HealthCare Technologies
May 6, 2025
Maintains: Equal-Weight
Price Target: $86 → $78
Current: $69.87
Upside: +11.64%
Becton, Dickinson and Company
May 6, 2025
Maintains: Overweight
Price Target: $280 → $196
Current: $167.22
Upside: +17.21%
Bausch + Lomb
May 6, 2025
Maintains: Equal-Weight
Price Target: $18 → $12
Current: $11.27
Upside: +6.48%
Teleflex
May 5, 2025
Maintains: Overweight
Price Target: $191 → $173
Current: $125.11
Upside: +38.28%
Baxter International
May 5, 2025
Maintains: Underweight
Price Target: $30 → $28
Current: $30.90
Upside: -9.39%
Solventum
Mar 5, 2025
Maintains: Equal-Weight
Price Target: $73 → $80
Current: $70.23
Upside: +13.91%
Tandem Diabetes Care
Mar 5, 2025
Downgrades: Equal-Weight
Price Target: $45 → $22
Current: $22.98
Upside: -4.26%
PROCEPT BioRobotics
Feb 26, 2025
Maintains: Overweight
Price Target: $105 → $95
Current: $53.11
Upside: +78.87%
DexCom
Feb 14, 2025
Maintains: Equal-Weight
Price Target: $75 → $82
Current: $84.67
Upside: -3.15%
Feb 12, 2025
Maintains: Equal-Weight
Price Target: $70 → $75
Current: $73.68
Upside: +1.79%
Feb 6, 2025
Maintains: Overweight
Price Target: $100 → $120
Current: $102.86
Upside: +16.66%
Dec 6, 2024
Maintains: Equal-Weight
Price Target: $104 → $102
Current: $82.26
Upside: +24.00%
Nov 11, 2024
Maintains: Overweight
Price Target: $234 → $317
Current: $310.67
Upside: +2.04%
Jul 15, 2024
Maintains: Equal-Weight
Price Target: $18 → $10
Current: $8.62
Upside: +16.01%
Jul 15, 2024
Maintains: Equal-Weight
Price Target: $104 → $145
Current: $111.50
Upside: +30.04%
Jul 15, 2024
Upgrades: Equal-Weight
Price Target: $65 → $85
Current: $95.75
Upside: -11.23%
Jul 15, 2024
Downgrades: Underweight
Price Target: $50 → $37
Current: $19.42
Upside: +90.53%
Dec 4, 2023
Maintains: Equal-Weight
Price Target: $225 → $215
Current: $226.43
Upside: -5.05%
Dec 4, 2023
Initiates: Overweight
Price Target: $36
Current: $13.06
Upside: +175.65%
Dec 11, 2017
Upgrades: Buy
Price Target: n/a
Current: $143.76
Upside: -